Physician profile
Susan E Dougherty
NPI 1295708774
$2,035.36
in general payments reported to CMS, 2019-2025
23 companies · $374 in 2025
The $374 reported for 2025 was more than what 92% of Advanced Practice Midwife providers received nationally (typical 2025 total: $70.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $112 · 2022: $550 · 2023: $556 · 2024: $443 · 2025: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,288 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,288.03 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $367.44 | 2022-2025 | Veozah |
| Abbvie INC. | $290.16 | 2021-2025 | |
| Pfizer INC. | $282.86 | 2022-2025 | |
| Merck Sharp & Dohme LLC | $215.85 | 2021-2025 | Gardasil 9, Vaxneuvance, Pneumovax 23 |
| Sumitomo Pharma America, INC. | $206.84 | 2024-2025 | Myfembree, Gemtesa |
| Bayer Healthcare Pharmaceuticals INC. | $96.33 | 2021-2024 | |
| Organon LLC | $86.78 | 2022-2025 | Nexplanon, Jada System |
| Biohaven Pharmaceutical Holding Company LTD. | $58.62 | 2022 | |
| Amgen INC. | $52.25 | 2022-2023 | Evenity, Prolia |
| Dexcom, INC. | $46.22 | 2024 | Dexcom G6 Transmitter |
| Myriad Women'S Health, INC. | $45.02 | 2023 | Myrisk |
| Gilead Sciences, INC. | $41.69 | 2022-2023 | |
| Exact Sciences Corporation | $41.16 | 2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $36.07 | 2021-2022 | |
| Biogen, INC. | $29.18 | 2025 | Zurzuvae |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $25.81 | 2023 | Rexulti |
| Janssen Pharmaceuticals, INC | $21.25 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $18.50 | 2022 | |
| Glaxosmithkline, LLC. | $17.36 | 2022 | |
| Therapeuticsmd, INC. | $15.30 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $14.64 | 2022 | |
| Daiichi Sankyo INC. | $13.38 | 2022 | |
| Coopersurgical, INC. | $12.65 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Susan Dougherty listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.